These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8611478

  • 1. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis.
    Asou H, Eguchi M, Suzukawa K, Morishita K, Tanaka K, Date M, Hamamoto K, Kamada N.
    Br J Haematol; 1996 Apr; 93(1):68-74. PubMed ID: 8611478
    [Abstract] [Full Text] [Related]

  • 2. EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia.
    Ohyashiki K, Ohyashiki JH, Fujieda H, Shimamoto T, Kawakubo K, Nakazawa S, Suzukawa K, Morishita K, Toyama K.
    Leukemia; 1994 Dec; 8(12):2169-73. PubMed ID: 7808006
    [Abstract] [Full Text] [Related]

  • 3. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26).
    Suzukawa K, Taki T, Abe T, Asoh H, Kamada N, Yokota J, Morishita K.
    Genomics; 1997 Jun 01; 42(2):356-60. PubMed ID: 9192861
    [Abstract] [Full Text] [Related]

  • 4. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N, Saito Y, Nakahata S, Bahirvani AG, Osato M, Morishita K.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):994-1000. PubMed ID: 27908728
    [Abstract] [Full Text] [Related]

  • 5. Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene.
    Asou H, Suzukawa K, Kita K, Nakase K, Ueda H, Morishita K, Kamada N.
    Jpn J Cancer Res; 1996 Mar 22; 87(3):269-74. PubMed ID: 8613429
    [Abstract] [Full Text] [Related]

  • 6. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.
    Hamaguchi H, Suzukawa K, Nagata K, Yamamoto K, Yagasaki F, Morishita K.
    Br J Haematol; 1997 Aug 22; 98(2):399-407. PubMed ID: 9266939
    [Abstract] [Full Text] [Related]

  • 7. EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22).
    De Weer A, Poppe B, Cauwelier B, Carlier A, Dierick J, Verhasselt B, Philippé J, Van Roy N, Speleman F.
    BMC Cancer; 2008 Jul 09; 8():193. PubMed ID: 18613965
    [Abstract] [Full Text] [Related]

  • 8. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis].
    Liu XP, Zhang MR, Dai Y, Zhang L, Li R, Hao YS, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May 09; 27(5):310-3. PubMed ID: 16875579
    [Abstract] [Full Text] [Related]

  • 9. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
    Behrens YL, Schienke A, Davenport C, Lentes J, Tauscher M, Steinemann D, Rasche M, Knirsch S, Joachim S, Reinhardt D, Schlegelberger B, Göhring G.
    Cancer Genet; 2021 Jun 09; 254-255():70-74. PubMed ID: 33647814
    [Abstract] [Full Text] [Related]

  • 10. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X, Qing A, Ji P, French SW, Mason H.
    Exp Mol Pathol; 2018 Apr 09; 104(2):130-133. PubMed ID: 29501750
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis.
    Russell M, Thompson F, Spier C, Taetle R.
    Leukemia; 1993 Oct 09; 7(10):1654-7. PubMed ID: 8412328
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Double t(1;7)(p36;p11) in a megakaryocytic crisis of chronic myelogenous leukemia with variant t(5;9;22).
    Hirata J, Umemura T, Nishimura J, Sadamura S, Sato H, Nawata H.
    Cancer Genet Cytogenet; 1993 Feb 09; 65(2):107-10. PubMed ID: 8453594
    [Abstract] [Full Text] [Related]

  • 15. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26).
    Suzukawa K, Parganas E, Gajjar A, Abe T, Takahashi S, Tani K, Asano S, Asou H, Kamada N, Yokota J.
    Blood; 1994 Oct 15; 84(8):2681-8. PubMed ID: 7919381
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
    Ogawa S, Kurokawa M, Tanaka T, Mitani K, Inazawa J, Hangaishi A, Tanaka K, Matsuo Y, Minowada J, Tsubota T, Yazaki Y, Hirai H.
    Oncogene; 1996 Jul 04; 13(1):183-91. PubMed ID: 8700545
    [Abstract] [Full Text] [Related]

  • 18. A case of chronic myelogenous leukemia with T lymphoblastic and megakaryoblastic mixed crisis.
    Iwamasa K, Yasukawa M, Fujita S.
    Jpn J Med; 1989 Jul 04; 28(1):89-95. PubMed ID: 2542679
    [Abstract] [Full Text] [Related]

  • 19. The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors.
    Theil KS, Cotta CV.
    Cancer Genet; 2014 May 04; 207(5):171-6. PubMed ID: 25027637
    [Abstract] [Full Text] [Related]

  • 20. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
    Kokate P, Dalvi R, Mandava S.
    J Cancer Res Ther; 2015 May 04; 11(4):1037. PubMed ID: 26881646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.